Institutional Ownership Innate Pharma Sa (IPHA)
This table provides information about the institutional ownership of Innate Pharma Sa (IPHA). We have compiled data on the 10 institutions that hold shares in the stock, with a total of 99,838 shares, which have been reported (via 13F filing form) to have a value of $215,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
51,224
shares
|
$107,058
0.0% of portfolio
|
Q2 2025
Added 17.69%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
26,617
shares
|
$55,629
0.0% of portfolio
|
Q2 2025
Added 9.68%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
11,661
shares
|
$24,371
0.0% of portfolio
|
Q2 2025
Reduced 23.91%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
5,957
shares
|
$12,450
0.0% of portfolio
|
Q2 2025
Reduced 33.82%
|
|
|
Gamma Investing LLC
Foster City, CA |
Jul 14, 2025 Q2 2025 |
3,456
shares
|
$7,223
0.0% of portfolio
|
Q2 2025
Added 54.77%
|
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
470
shares
|
$982
0.0% of portfolio
|
Q2 2025
Reduced 30.37%
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
307
shares
|
$641
0.0% of portfolio
|
Q3 2024
Reduced 25.49%
|
|
|
Optiver Holding B.V.
Amsterdam, P7 |
Aug 14, 2025 Q2 2025 |
101
shares
|
$211
0.0% of portfolio
|
Q4 2024
Reduced 99.88%
|
|
|
Principal Securities, Inc.
Des Moines, IA |
Aug 11, 2025 Q2 2025 |
45
shares
|
$94
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|